BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 17890917)

  • 1. Basal cell carcinoma with matrical differentiation: expression of beta-catenin [corrected] and osteopontin.
    Del Sordo R; Cavaliere A; Sidoni A
    Am J Dermatopathol; 2007 Oct; 29(5):470-4. PubMed ID: 17890917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal cell carcinoma with matrical differentiation: a case study with analysis of beta-catenin.
    Haskell HD; Haynes HA; McKee PH; Redston M; Granter SR; Lazar AJ
    J Cutan Pathol; 2005 Mar; 32(3):245-50. PubMed ID: 15701088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal cell carcinoma with matrical differentiation in a transplant patient: a case report and review of the literature.
    Ali F; Brown A; Gottwald L; Thomas J
    J Cutan Pathol; 2005 Jul; 32(6):445-8. PubMed ID: 15953381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression patterns of hair and epithelial keratins and transcription factors HOXC13, LEF1, and beta-catenin in a malignant pilomatricoma: a histological and immunohistochemical study.
    Cribier B; Worret WI; Braun-Falco M; Peltre B; Langbein L; Schweizer J
    J Cutan Pathol; 2006 Jan; 33(1):1-9. PubMed ID: 16441405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokeratin profile in basal cell carcinoma.
    Alessi E; Venegoni L; Fanoni D; Berti E
    Am J Dermatopathol; 2008 Jun; 30(3):249-55. PubMed ID: 18496426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilomatrix carcinoma of the clitoris.
    Gazic B; Sramek-Zatler S; Repse-Fokter A; Pizem J
    Int J Surg Pathol; 2011 Dec; 19(6):827-30. PubMed ID: 21427098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-catenin expression in benign and malignant pilomatrix neoplasms.
    Hassanein AM; Glanz SM
    Br J Dermatol; 2004 Mar; 150(3):511-6. PubMed ID: 15030335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Panfollicular carcinoma or trichoblastic carcinoma with panfollicular differentiation?
    Fedeles F; Cha J; Chaump M; Theroux B; Farrell D; Dufresne R; Robinson-Bostom L
    J Cutan Pathol; 2013 Nov; 40(11):976-81. PubMed ID: 24320809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal cell carcinoma and pilomatrixoma mirror human follicular embryogenesis as reflected by their differential expression patterns of SOX9 and β-catenin.
    Krahl D; Sellheyer K
    Br J Dermatol; 2010 Jun; 162(6):1294-301. PubMed ID: 20105172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal Cell Carcinoma With Matrical Differentiation: Clinicopathologic, Immunohistochemical, and Molecular Biological Study of 22 Cases.
    Kyrpychova L; Carr RA; Martinek P; Vanecek T; Perret R; Chottová-Dvořáková M; Zamecnik M; Hadravsky L; Michal M; Kazakov DV
    Am J Surg Pathol; 2017 Jun; 41(6):738-749. PubMed ID: 28368926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell adhesion protein expression in melanocytic matricoma.
    Soler AP; Burchette JL; Bellet JS; Olson JA
    J Cutan Pathol; 2007 Jun; 34(6):456-60. PubMed ID: 17518772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichoepithelioma with an adjacent basal cell carcinoma, transformation or collision?
    Wallace ML; Smoller BR
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 2):343-5. PubMed ID: 9270544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanocytic matricoma with melanocytic atypia: report of a unique case and review of the literature.
    Zussman J; Sheth S; Ra SH; Binder SW
    Am J Dermatopathol; 2011 Jul; 33(5):508-12. PubMed ID: 21252635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Basal cell carcinoma with matrical differentiation].
    Goldman-Lévy G; Frouin E; Soubeyran I; Maury G; Guillot B; Costes V
    Ann Pathol; 2015 Apr; 35(2):159-63. PubMed ID: 25746660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma.
    Sellheyer K; Krahl D
    Br J Dermatol; 2011 Jan; 164(1):141-7. PubMed ID: 20846311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-catenin in canine skin: immunohistochemical pattern of expression in normal skin and cutaneous epithelial tumours.
    Bongiovanni L; Malatesta D; Brachelente C; D'Egidio S; Della Salda L
    J Comp Pathol; 2011; 145(2-3):138-47. PubMed ID: 21388636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation and apoptosis in pilomatrixoma.
    Ishige T; Kikuchi K; Miyazaki Y; Hara H; Yoshino A; Terui T; Katayama Y; Kusama K; Nemoto N
    Am J Dermatopathol; 2011 Feb; 33(1):60-4. PubMed ID: 21239898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
    Yang HM; Cabral E; Dadras SS; Cassarino DS
    Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin tumors with matrical differentiation: lessons from hair keratins, beta-catenin and PHLDA-1 expression.
    Battistella M; Carlson JA; Osio A; Langbein L; Cribier B
    J Cutan Pathol; 2014 May; 41(5):427-36. PubMed ID: 24673383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of androgen receptor by fibroepithelioma of Pinkus: evidence supporting classification as a basal cell carcinoma variant?
    Katona TM; Ravis SM; Perkins SM; Moores WB; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):7-12. PubMed ID: 17284955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.